Business
Psycheceutical’s Chief Visionary Officer Zappy Zapolin Speaking at Legacy Investment Summit Alongside Entrepreneur Peter Diamandis
Psycheceutical’s Chief Visionary Officer Zappy Zapolin Speaking at Legacy Investment Summit Alongside Entrepreneur Peter Diamandis.
About this update from Blue Water Ventures International, Inc.
[{"type":"text","content":"Psycheceutical’s Chief Visionary Officer Zappy Zapolin Speaking at Legacy Investment Summit Alongside Entrepreneur Peter DiamandisZapolin Set to Outline the Lucrative Financial Potential of Psychedelic MedicineMIAMI, FL — March 28, 2022 — Psycheceutical, Inc. (a wholly-owned subsidiary of Psycheceutical Bioscience, Inc. (OTC: BWVI), a bioscience company dedicated to the development and commercialization of psychedelic medicines, has announced that Chief Visionary Officer Zappy Zapolin will be a featured presenter at the esteemed Legacy Investment Summit 2022, to be held at the Mandarin Oriental Hotel in Washington, D.C. on March 31 and April 1.Zapolin’s session, entitled “Psychedelics: The Medicine of the Future,” aims to educate attendees about the very real potential of funding their retirement by being early investors in this emerging sector. Experts predict that psychedelic medicine will provide a major breakthrough in the area of mental health and addiction treatment, with an estimated global market size in the hundreds of billions.As an investor, advisor, and filmmaker, Zappy Zapolin is one of the foremost experts in psychedelic medicinal therapies and companies. In the early days of the internet, Zapolin purchased and sold multiple domain names for up to 8,650% returns. This ability to identify massive trends has put Zappy ahead of the mainstream investing curve for decades. Since then, he’s made two documentaries on the healing power of psychedelics and invested in early-stage medical psychedelic companies for gains up to 1,000%.Keynoting the conference is renowned entrepreneur and investor Peter Diamandis. Recently named by Fortune as one of the “World’s 50 Greatest Leaders,” Diamandis has started over 20 companies in the areas of longevity, space, venture capital, and education. He is the founder and executive chairman of the XPRIZE Foundation, the executive founder of Singularity University, co-founder of BOLD Capital Partners, and co-founder and Vice Chairman of Celularity, Inc., a cellular therapeutics company.“It is truly an honor to be part of one of the premier investment conferences in the world,” commented Zapolin. “My passion is bringing people into the world of psychedelic medicine, both through financial investment as well as personal experiences. Investing in psychedelic companies today is like buying pharm...